Related Experiment Video
Updated: Jan 16, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Risk Factors Associated With Progression to Clinical Candida auris Infection Among Adults With Previous
Katharine E Saunders1,2, Argentina Charles2, Timothy J Doyle2,3
1Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Background:
Candida auris is an emerging fungal organism that has caused outbreaks in healthcare settings and become a major public health concern, particularly among medically vulnerable populations.
Methods:
Using a retrospective case-control design, we investigated factors associated with C. auris clinical cases after prior colonization among patients identified in Florida healthcare facilities during 1 January 2019-31 December 2023.
Results:
We identified 105 case-patients with documented clinical specimens after colonization and 578 control subjects with colonization only. Factors significantly associated with clinical cases included presence of ≥5 comorbid conditions (odds ratio [OR], 10.02 [95% confidence interval {CI}, 4.07-24.7]), ≥ 4 invasive devices (OR, 2.92 [95% CI, 1.70-5.03]), or ≥3 recent medical procedures (OR, 2.32 [95% CI, 1.19-4.55]). In addition, fully dependent care required for eating (OR, 2.80), mobility (OR, 2.15), and transferring (OR, 1.82) were associated with clinical case progression.
Conclusions:
We found a significant association with progression from screening colonization to clinical C. auris cases among patients with multiple comorbidities, invasive devices, recent invasive procedures, and poor functional status. Identifying risk factors for clinical progression of C. auris after colonization could enable facilities to implement efficient testing protocols and infection prevention and control measures to help prevent morbidity associated with invasive infections.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Urinary Tract Infection II: Pathophysiology
Fungal Phylum Microsporidia
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

